These findings suggest that QZD may exert therapeutic effects in high-risk locally advanced NPC by modulating multiple oncogenic pathways, particularly through apoptosis regulation and PI3K-Akt signaling inhibition, which are crucial for tumor survival and drug resistance. Here, AKT1 is linked to nasopharyngeal carcinoma.